🔗 Permalink

Inventor profile of:

Peter S. Linsley

City:

Seattle, Washington

Country:

United States

Published Applications:

Last publication date:

2024-12-12

Top Assignees for applications by Peter S. Linsley

The entities that hold a legal rights for patent applications filed by inventor Linsley Peter S.:

BRISTOL-MYERS SQUIBB COMPANY 14 Princeton, NJ United States
Merck Sharp Dohme Corp. 8 Rahway, NJ United States
ROSETTA INPHARMATICS LLC 6 SEATTLE, WA United States
THE NETHERLANDS CANCER INSTITUTE 5 Amsterdam, Netherlands
Emory University 1 Atlanta, GA United States
Merck & Co., Inc. 1 Rahway, NJ United States
BRISTOL-MYERS SQUIBB CO. 1 Princeton, NJ United States
Provention Bio, Inc. 1 Red Bank, NJ United States
FRED HUTCHINSON CANCER RESEARCH CENTER 1 Seattle, WA United States
BRISTOL-MYERS SQUIBB COMPANY 1 NEW YORK, NY United States
Benaroya Research Institute at Virginia Mason 1 Seattle, WA United States
YALE UNIVERSITY 1 New Haven, CT United States
Dharmacon, Inc. 1 Lafayette, CO United States
Netherlands Cancer Institute 1 Amsterdam, Netherlands
Merck & Co., Inc. 1 Rahway, NJ United States

Recent patent applications by Linsley Peter S.

Peter S. Linsley from Seattle, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-12-12

US20240409633A1

Chemistry; metallurgy

Methods and Compositions for Preventing Type 1 Diabetes

#2 | 2022-02-10

US20220041720A1

Chemistry; metallurgy

Methods and compositions for preventing type 1 diabetes

#3 | 2021-04-22

US20210115107A1

Chemistry; metallurgy

METHODS OF TREATMENT USING CTLA4 MOLECULES

#4 | 2019-06-20

US20190185538A1

Chemistry; metallurgy

METHODS OF TREATMENT USING CTLA4 MOLECULES

#5 | 2018-10-25

US20180305768A1

Chemistry; metallurgy

DIAGNOSIS AND PROGNOSIS OF BREAST CANCER PATIENTS

#6 | 2018-05-17

US20180134764A9

Chemistry; metallurgy

METHODS OF TREATMENT USING CTLA4 MUTANT MOLECULES

#7 | 2017-12-28

US20170369549A1

Chemistry; metallurgy

Methods of treatment using CTLA4 mutant molecules

#8 | 2015-03-12

US20150071914A1

Chemistry; metallurgy

Methods of treatment using CTLA4 mutant molecules

#9 | 2013-05-09

US20130116145A1

Chemistry; metallurgy

Diagnosis and prognosis of breast cancer patients

#10 | 2012-03-22

US20120072124A1

Chemistry; metallurgy

GENES ASSOCIATED WITH PROGRESSION AND RESPONSE IN CHRONIC MYELOID LEUKEMIA AND USES THEREOF

#11 | 2012-03-01

US20120052065A1

Chemistry; metallurgy

Methods of treatment using CTLA4 mutant molecules

#12 | 2011-12-08

US20110301048A1

Chemistry; metallurgy

DIAGNOSIS AND PROGNOSIS OF BREAST CANCER PATIENTS

#13 | 2011-10-13

US20110250591A1

Chemistry; metallurgy

Method for selecting SIRNAs from a plurality of SIRNAs for gene silencing

#14 | 2011-03-29

US10283610

Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell

#15 | 2010-07-22

US20100183612A1

Chemistry; metallurgy

METHODS OF TREATMENT USING CTLA4 MUTANT MOLECULES

#16 | 2010-02-11

US20100035966A1

Chemistry; metallurgy

Methods and compositions for regulating cell cycle progression

#17 | 2009-12-24

US20090317397A1

Chemistry; metallurgy

Soluble CTLA4 mutant molecules and uses thereof

#18 | 2009-07-23

US20090186037A1

Chemistry; metallurgy

METHODS FOR INHIBITING AN IMMUNE RESPONSE BY BLOCKING THE GP39/CD40 AND CTLA4/CD28/B7 PATHWAYS AND COMPOSITIONS FOR USE THEREWITH

#19 | 2009-06-18

US20090157326A1

Chemistry; metallurgy

Diagnosis and prognosis of breast cancer patients

#20 | 2009-04-07

US10172118

Diagnosis and prognosis of breast cancer patients

#21 | 2009-02-12

US20090041769A1

Chemistry; metallurgy

Methods of treatment using CTLA4 mutant molecules

#22 | 2008-11-25

US9898195

Methods for treating immune system diseases using a soluble CTLA4 molecule

#23 | 2008-09-25

US20080234941A1

Chemistry; metallurgy

Method of designing siRNAs for gene silencing

#24 | 2008-07-03

US20080160022A1

Chemistry; metallurgy

Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules

#25 | 2008-02-07

US20080031876A1

Chemistry; metallurgy

Soluble CTLA4 mutant molecules

#26 | 2007-12-04

US10155514

Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules

#27 | 2007-07-05

US20070154931A1

Chemistry; metallurgy

Genes associated with progression and response in chronic myeloid leukemia and uses thereof

#28 | 2007-06-28

US20070149468A1

Chemistry; metallurgy

Methods and compositions for RNA interference

#29 | 2007-06-14

US20070134660A1

Physics

Methods for identifying modulators of kinesin activity

#30 | 2007-01-30

US10342887

Methods of assigning treatment to breast cancer patients

#31 | 2006-12-28

US20060292623A1

Physics

Signature genes in chronic myelogenous leukemia

#32 | 2006-09-12

US9609915

Soluble CTLA4 mutant molecules and uses thereof

#33 | 2006-08-22

US9865321

Soluble CTLA4 mutant molecules

#34 | 2006-07-04

US8459766

Methods for blocking binding of CD28 receptor to B7

#35 | 2006-06-29

US20060141501A1

Physics

Iterative probe design and detailed expression profiling with flexible in-situ synthesis arrays

#36 | 2006-05-09

US9049865

Method of inhibiting immune system destruction of transplanted viable cells

#37 | 2006-03-14

US9561487

Iterative probe design and detailed expression profiling with flexible in-situ synthesis arrays

#38 | 2005-10-06

US20050223427A1

Chemistry; metallurgy

Modified polynucleotides for reducing off-target effects in RNA interference

#39 | 2005-09-29

US20050214313A1

Chemistry; metallurgy

Methods of treatment using CTLA4 mutant molecules

#40 | 2005-09-15

US20050202011A1

Chemistry; metallurgy

Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith

#41 | 2005-08-18

US20050181385A1

Chemistry; metallurgy

Synthetic lethal screen using RNA interference

#42 | 2005-08-04

US20050169919A1

Chemistry; metallurgy

Methods for treating cancer and infectious disease by blocking CTLA4-B7 interactions

#43 | 2005-05-03

US9454651

Method to inhibit T cell interactions with soluble B7

InventorID:

235955 ⎘